Novistra Capital
transaction-bg-2560x945

December 2021

United States & Philippines

Novistra Capital advised Cloud Development Resources on its majority sale to emids

Client

Cloud Development Resources

Deal Type

Sell-Side M&A

Deal Team

Ripun-1-120x120

Ripun Jai Mehta

Managing Partner

Ash-120x120

Ash Mittel

Managing Director

Pankaj-1-120x120

Pankaj Arora

Managing Director

Client Description

Cloud Development Resources (CDR) is a premier low-code consulting firm based in North America, delivering enterprise-grade web and mobile applications on the OutSystems platform. CDR supports clients through full-spectrum digital transformation solutions, with a growing presence in healthcare and regulated industries.

emids, headquartered in Nashville, is a leading digital transformation and technology partner to the healthcare industry. The company provides custom software development, data engineering, and strategic consulting across the healthcare ecosystem—from providers and payers to healthtech innovators.

Approach

CDR engaged Novistra Capital to advise on a strategic transaction that would help scale its capabilities in healthcare and accelerate market expansion. Novistra identified emids as a strong strategic fit—offering complementary strengths in digital engineering, deep healthcare domain expertise, and global delivery infrastructure.

Drawing on its track record in both low-code and healthcare technology, Novistra managed a high-conviction process from initial positioning to close, ensuring alignment of growth priorities and delivery models.

Outcome

CDR was acquired by emids, establishing the healthcare industry’s first dedicated low-code practice. The combined platform will enable clients to deliver transformative digital experiences at speed, powered by the convergence of low-code and modern digital engineering.

This transaction adds to Novistra’s deep experience across low-code enablement, healthcare IT, and digital transformation services—highlighting continued interest in platforms that combine sector specialisation with scalable tech capability.

Rectangle-426-1-scaled-2560x718

“ Novistra proved themselves invaluable and their expertise throughout the process was key in our joining forces with emids. Combining modern digital engineering with low-code will significantly enhance our ability to transform the patient experience at an unprecedented pace.”

person-placeholder-120x88

Clark Swain

CEO, Cloud Development Resources

Press Releases

techservices-2560x392

December, 2021

Novistra Capital advises Cloud Development Resources on its sale to emids

Read more

Related Transactions

Acquired

Buy-side advisor to CX1 Capital

Novistra Capital advises CX1 Capital on its acquisition of SatCom Marketing

Novistra Capital advises CX1 Capital on its acquisition of SatCom Marketing

Outcome: Exclusive buy-side advisor to CX1 Capital, a tech-driven investment firm that focuses on lower middle market buy & build strategies using AI.

Acquired by

A portfolio company of

Sell-side advisor to CTI Data

Novistra Capital advises CTI Data on its sale to OneSix

Exclusive sell-side advisor to CTI Data, a leading data consultancy, on its sale to OneSix,...

Outcome: Acquisition creates a differentiated Snowflake data and scaled AI platform.

Acquired by

A portfolio company of

Sell-side advisor to Yexle

Novistra Capital advises Yexle on its sale to IGT Solutions, an EQT portfolio company

Exclusive sell-side advisor to Yexle, a leading Appian solutions and services partner.

Outcome: Added cutting-edge Appian delivery capabilities to IGT’s digital transformation practice.

Acquired by

A portfolio company of

Sell-side advisor to NetServ

Novistra Capital advised NetServ on its acquisition by Accion Labs, a portfolio company of TA Associates

Served as exclusive sell-side advisor to NetServ on its acquisition by Accion Labs, a global...

Outcome: Strengthened engineering capabilities and delivery presence across key markets

Acquired by

A portfolio company of

Sell-side advisor to SG Analytics

Novistra Capital advised SG Analytics on its acquisition by Straive, a portfolio company of EQT

SG Analytics engaged Novistra Capital as its exclusive sell-side advisor on its acquisition by Straive,...

Outcome: Created one of the leading integrated data and analytics platforms

Majority investment in

Buy-side advisor to Excelra

Novistra Capital advised Excelra on its majority investment in Anilitiks

Served as exclusive buy-side advisor to Excelra on its acquisition of Anilitiks, strengthening Excelra’s HEOR...

Outcome: Expanded Excelra’s data-driven Life Sciences solutions portfolio

Merged with

Buy-side advisor to ACN Healthcare

Novistra Capital advised ACN Healthcare on its merger with Rapid Care’s RCM business

Advised ACN Healthcare on its merger with the RCM business of Rapid Care Group, creating...

Outcome: Merger created a scaled, integrated healthcare RCM platform

License agreement with

Financial advisor to IDD Bio Tech

Novistra Capital advised IDD Biotech on its license agreement with Enzene Biosciences, a subsidiary of Alkem Labs

IDD Biotech appointed Novistra Capital to structure and negotiate a licensing deal for its CD19...

Outcome: Exclusive licensing agreement with Enzene Biosciences completed

Acquired by

Sell-side advisor to Pacific BPO

Novistra Capital advised Pacific BPO on its sale to Access Healthcare

Exclusive advisor to Pacific BPO on its sale to Access Healthcare, creating one of the...

Outcome: Completed sale of Pacific BPO to Access Healthcare

Acquired by

Sell-side advisor to Global Revenue Cycle Partners

Novistra Capital advises Global Revenue Cycle Partners on its majority exit to ACN Technologies

Advised Global Revenue Cycle Partners on its majority sale to ACN Technologies, creating an integrated...

Outcome: Leveraged ACN’s US and European presence to expand offerings

Rectangle-426-1-scaled-2560x718

Clarity starts with
a conversation